Exogenous agent diffusivity in tissues as a biomarker of diabetes mellitus pathology /D. K. Tuchina, A. N. Bashkatov, A. B. Bucharskaya, V. V. Tuchin

Электронный ресурс
Другой Автор
Bashkatov, Alexey N.
Bucharskaya, Alla B.
Tuchin, Valery V.
Tuchina, Daria K.
Источник
Proceedings of SPIE 2019 Vol. 10877 : Dynamics and fluctuations in biomedical photonics XVI. P. 108770X-1-108770X-7
Аннотация
The study offers a possibility to use such biocompatible chemical as glycerol as a biomarker for early diagnostics of diabetes mellitus complications, in particular, for assessing the degree of myocardial lesion evidence by the stage of skin glycation during diabetes development and treatment. The study was aimed to find the difference in glycerol permeability through rat soft tissues of control and diabetic groups in order to show the possibility of glycerol usage as a biomarker of diabetes impact on different organs. The investigation presents transition the experimental studies from ex vivo to in vivo conditions.
Всего оценка: 0
Нет записей для отображения.
 
 
 
02012nab a2200349 c 4500
001
 
 
vtls000672252
003
 
 
RU-ToGU
005
 
 
20191224165100.0
007
 
 
cr |
008
 
 
191217|2019    xxu     s         a eng d
024
7
$a 10.1117/12.2506644 $2 doi
035
$a to000672252
039
9
$a 201912241651 $b cat34 $c 201912171602 $d VLOAD $y 201912171545 $z VLOAD
040
$a RU-ToGU $b rus $c RU-ToGU
245
1
0
$a Exogenous agent diffusivity in tissues as a biomarker of diabetes mellitus pathology $c D. K. Tuchina, A. N. Bashkatov, A. B. Bucharskaya, V. V. Tuchin
504
$a Библиогр.: 32 назв.
520
3
$a The study offers a possibility to use such biocompatible chemical as glycerol as a biomarker for early diagnostics of diabetes mellitus complications, in particular, for assessing the degree of myocardial lesion evidence by the stage of skin glycation during diabetes development and treatment. The study was aimed to find the difference in glycerol permeability through rat soft tissues of control and diabetic groups in order to show the possibility of glycerol usage as a biomarker of diabetes impact on different organs. The investigation presents transition the experimental studies from ex vivo to in vivo conditions.
653
$a глицерин
653
$a биомаркеры
653
$a аллоксановый диабет
653
$a миокард
655
4
$a статьи в журналах
700
1
$a Bashkatov, Alexey N.
700
1
$a Bucharskaya, Alla B.
700
1
$a Tuchin, Valery V.
700
1
$a Tuchina, Daria K.
773
0
$t Proceedings of SPIE $d 2019 $g Vol. 10877 : Dynamics and fluctuations in biomedical photonics XVI. P. 108770X-1-108770X-7 $x 0277-786X
852
4
$a RU-ToGU
856
4
$u http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000672252
908
$a статья
999
$a VIRTUA               
999
$a VTLSSORT0070*0080*0240*0350*0400*2450*5040*5200*6530*6531*6532*6533*6550*7003*7000*7001*7002*7730*8520*8560*9080*9992
Нет комментариев.
Предмет
статьи в журналах
Резюме
The study offers a possibility to use such biocompatible chemical as glycerol as a biomarker for early diagnostics of diabetes mellitus complications, in particular, for assessing the degree of myocardial lesion evidence by the stage of skin glycation during diabetes development and treatment. The study was aimed to find the difference in glycerol permeability through rat soft tissues of control and diabetic groups in order to show the possibility of glycerol usage as a biomarker of diabetes impact on different organs. The investigation presents transition the experimental studies from ex vivo to in vivo conditions.